We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+8.89%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.6B
AUM Growth
-$3.14B
Cap. Flow
-$4.13B
Cap. Flow %
-28.38%
Top 10 Hldgs %
20.74%
Holding
1,655
New
313
Increased
216
Reduced
349
Closed
770

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$214M
2
MDT icon
Medtronic
MDT
+$123M
3
CHTR icon
Charter Communications
CHTR
+$97.9M
4
MRK icon
Merck
MRK
+$94M
5
ZTS icon
Zoetis
ZTS
+$91.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$253M
2
BIDU icon
Baidu
BIDU
+$120M
3
STZ icon
Constellation Brands
STZ
+$110M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$104M
5
ABT icon
Abbott
ABT
+$98.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.1%
2 Technology 16.39%
3 Industrials 11.22%
4 Consumer Discretionary 9.86%
5 Financials 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
876
DELISTED
Strongbridge Biopharma plc.
SBBP
$58K ﹤0.01%
11,870
-40,676
-77% -$208K
SDLP
877
DELISTED
SEADRILL PARTNERS LLC
SDLP
$58K ﹤0.01%
+1,566
New +$55.4K
SAN icon
878
Banco Santander
SAN
$210B
$57K ﹤0.01%
+11,791
New +$59.3K
SIOX
879
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$54K ﹤0.01%
2,788
-55,294
-95% -$1.01M
MLNT
880
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$48K ﹤0.01%
+2,423
New +$61.3K
CBL
881
DELISTED
CBL& Associates Properties, Inc.
CBL
$44K ﹤0.01%
+11,134
New +$53.4K
PDS
882
Precision Drilling
PDS
$974M
$42K ﹤0.01%
615
-55,060
-99% -$4.01M
VEON icon
883
VEON
VEON
$3.95B
$31K ﹤0.01%
+432
New +$31.3K
ONSIW
884
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
$1K ﹤0.01%
125,400
– –
AA icon
885
Alcoa
AA
$13.2B
– –
-90,947
Closed -$4.26M
AAT
886
American Assets Trust
AAT
$1.4B
– –
-35,820
Closed -$1.37M
ABR icon
887
Arbor Realty Trust
ABR
$998M
– –
-246,950
Closed -$2.58M
ACAD icon
888
Acadia Pharmaceuticals
ACAD
$5.03B
– –
-198,214
Closed -$3.03M
ACLS icon
889
Axcelis
ACLS
$4.33B
– –
-114,795
Closed -$2.27M
ACR
890
ACRES Commercial Realty
ACR
$108M
– –
-18,735
Closed -$572K
ACRE
891
Ares Commercial Real Estate
ACRE
$270M
– –
-40,428
Closed -$558K
ADI icon
892
Analog Devices
ADI
$190B
– –
-6,225
Closed -$597K
ADM icon
893
Archer Daniels Midland
ADM
$36.9B
– –
-58,151
Closed -$2.67M
AEIS icon
894
Advanced Energy
AEIS
$13B
– –
-274,904
Closed -$16M
AGO icon
895
Assured Guaranty
AGO
$3.34B
– –
-29,823
Closed -$1.07M
AGX icon
896
Argan
AGX
$8.37B
– –
-25,744
Closed -$1.05M
AIV
897
Aimco
AIV
$383M
– –
-238,589
Closed -$1.34M
AJG icon
898
Arthur J. Gallagher & Co
AJG
$63.6B
– –
-587,044
Closed -$38.3M
ALLY icon
899
Ally Financial
ALLY
$13.3B
– –
-17,939
Closed -$471K
ALNY icon
900
Alnylam Pharmaceuticals
ALNY
$29.3B
– –
-26,553
Closed -$2.62M
34 35
36
37 38

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2018 Portfolio in Review

As of Q3 2018, Marshall Wace North America held 1,655 positions worth $14.6B, down 18% from $17.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Marshall Wace North America withdrew a net $4.13B in Q3 2018, closing 770 positions and reducing 349 holdings. Its most notable exit was Baidu, an estimated $120M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Marshall Wace North America opened a new position in Medtronic worth $130M.

  • Marshall Wace North America's largest Q3 2018 buy was Medtronic: 1,325,878 shares worth $130M.
  • Marshall Wace North America added most to Alphabet (Google) Class A in Q3 2018, an estimated $214M increase.
  • Marshall Wace North America's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $253M.
  • Marshall Wace North America fully exited Baidu in Q3 2018, selling an estimated $120M.
  • Marshall Wace North America's ten largest holdings make up 21% of its $14.6B portfolio in Q3 2018.
  • Marshall Wace North America opened 313 new positions and closed 770 in Q3 2018.
  • Marshall Wace North America's portfolio value fell 18% quarter-over-quarter to $14.6B.

Based on Marshall Wace North America's 13F filing for Q3 2018, filed 14 Nov 2018.